Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Emergent Biosolutions Inc shares valued at $61,100 were sold by Zoon Kathryn C on Jun 04 ’24. At $6.11 per share, Zoon Kathryn C sold 10,000 shares. The insider’s holdings dropped to 54,482 shares worth approximately $0.48 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Zoon Kathryn C sold 1,830 shares, netting a total of over 8,436 in proceeds. Following the sale of shares at $4.61 each, the insider now holds 64,482 shares.
Before that, Zoon Kathryn C had sold 1,089 shares from its account. In a trade valued at $6,294, the Director traded Emergent Biosolutions Inc shares for $5.78 each. Upon closing the transaction, the insider’s holdings decreased to 1,089 shares, worth approximately $0.43 million.
As published in their initiating research note from Rodman & Renshaw on August 22, 2024, Emergent Biosolutions Inc [EBS] has been a Buy and the price target has been revised to $16. Analysts at The Benchmark Company upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in early March. Earlier on August 29, 2023, The Benchmark Company downgraded its rating. Their new recommendation was “a Hold” for EBS stock which previously was a “a Buy”.
Analyzing EBS Stock Performance
During the last five days, there has been a drop of approximately -4.48%. Over the course of the year, Emergent Biosolutions Inc shares have jumped approximately 264.58%. Shares of the company reached a 52-week high of $15.10 on 07/30/24 and a 52-week low of $1.42 on 02/06/24. A 50-day SMA is recorded $8.43, while a 200-day SMA reached $5.67. Nevertheless, trading volume fell to 1.38 million shares from 1.84 million shares the previous day.
Support And Resistance Levels for Emergent Biosolutions Inc (EBS)
According to the 24-hour chart, there is a support level at 8.48, which, if violated, would cause prices to drop to 8.21. In the upper region, resistance lies at 9.15. The next price resistance is at 9.55. RSI (Relative Strength Index) is 50.37 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.25, which suggests the price will decrease in the coming days. Percent R is at 78.51%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
